Host cell protein characterisation during the downstream processing of monoclonal antibodies from mammalian cells

The biopharmaceutical industry is at a pivotal moment of its short history, with ‘blockbuster’ monoclonal antibody (mAb) biosimilars emerging and the ‘next generation’ of molecules beginning to make their mark. Concomitantly, regulatory constraints on manufacturers have amplified, with processes now...

Full description

Bibliographic Details
Main Author: Tarrant, R. D. R.
Published: University College London (University of London) 2014
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626660
id ndltd-bl.uk-oai-ethos.bl.uk-626660
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-6266602016-08-04T03:29:31ZHost cell protein characterisation during the downstream processing of monoclonal antibodies from mammalian cellsTarrant, R. D. R.2014The biopharmaceutical industry is at a pivotal moment of its short history, with ‘blockbuster’ monoclonal antibody (mAb) biosimilars emerging and the ‘next generation’ of molecules beginning to make their mark. Concomitantly, regulatory constraints on manufacturers have amplified, with processes now requiring in-depth characterisation. Scale-down mimics of process steps and supportive analytical methods are therefore becoming indispensable. The work presented in this thesis has focussed on the downstream processing of mammalian cell derived mAbs. With industrial relevance considered throughout, a scale-down primary recovery and chromatography process was implemented. This was supported by ELISA, mass spectrometry and gel-based methods to investigate host cell proteins (HCPs), which are rigorously controlled process-related impurities. The interface of upstream and downstream processing was identified as a critical aspect of bioprocessing which can dictate impurity profiles. Preliminary work demonstrated that small particle debris and cell properties, such as viability and size, all contribute to primary recovery performance. Subsequent investigations of mild hypothermic cell culture showed that cell membrane rigidity also plays an important role, as centrifugation clarification was up to 4% greater for temperature adapted cells. However, HCPs were adversely affected, increasing by ~50%. To further understand harvest material properties, a polyethylenimine flocculation process was developed. This improved centrifugation performance, by reducing shear susceptibility, and increased subsequent depth filtration capacity up to 2.1 fold. Benefits to purification were also demonstrated, with DNA and negatively charged HCPs being removed. Protein A chromatography was the final focus of work, owing to its prominence in purification. Four different resins were evaluated; non-specific adsorption of HCPs was only pronounced for the resin with a controlled pore glass back-bone, but ‘product association’ was significant for all. To help analyse this sub-set of HCPs, an immuno association disruption methodology was developed and may prove invaluable in future characterisation efforts to improve product purity.660.6University College London (University of London)http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626660http://discovery.ucl.ac.uk/1419145/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 660.6
spellingShingle 660.6
Tarrant, R. D. R.
Host cell protein characterisation during the downstream processing of monoclonal antibodies from mammalian cells
description The biopharmaceutical industry is at a pivotal moment of its short history, with ‘blockbuster’ monoclonal antibody (mAb) biosimilars emerging and the ‘next generation’ of molecules beginning to make their mark. Concomitantly, regulatory constraints on manufacturers have amplified, with processes now requiring in-depth characterisation. Scale-down mimics of process steps and supportive analytical methods are therefore becoming indispensable. The work presented in this thesis has focussed on the downstream processing of mammalian cell derived mAbs. With industrial relevance considered throughout, a scale-down primary recovery and chromatography process was implemented. This was supported by ELISA, mass spectrometry and gel-based methods to investigate host cell proteins (HCPs), which are rigorously controlled process-related impurities. The interface of upstream and downstream processing was identified as a critical aspect of bioprocessing which can dictate impurity profiles. Preliminary work demonstrated that small particle debris and cell properties, such as viability and size, all contribute to primary recovery performance. Subsequent investigations of mild hypothermic cell culture showed that cell membrane rigidity also plays an important role, as centrifugation clarification was up to 4% greater for temperature adapted cells. However, HCPs were adversely affected, increasing by ~50%. To further understand harvest material properties, a polyethylenimine flocculation process was developed. This improved centrifugation performance, by reducing shear susceptibility, and increased subsequent depth filtration capacity up to 2.1 fold. Benefits to purification were also demonstrated, with DNA and negatively charged HCPs being removed. Protein A chromatography was the final focus of work, owing to its prominence in purification. Four different resins were evaluated; non-specific adsorption of HCPs was only pronounced for the resin with a controlled pore glass back-bone, but ‘product association’ was significant for all. To help analyse this sub-set of HCPs, an immuno association disruption methodology was developed and may prove invaluable in future characterisation efforts to improve product purity.
author Tarrant, R. D. R.
author_facet Tarrant, R. D. R.
author_sort Tarrant, R. D. R.
title Host cell protein characterisation during the downstream processing of monoclonal antibodies from mammalian cells
title_short Host cell protein characterisation during the downstream processing of monoclonal antibodies from mammalian cells
title_full Host cell protein characterisation during the downstream processing of monoclonal antibodies from mammalian cells
title_fullStr Host cell protein characterisation during the downstream processing of monoclonal antibodies from mammalian cells
title_full_unstemmed Host cell protein characterisation during the downstream processing of monoclonal antibodies from mammalian cells
title_sort host cell protein characterisation during the downstream processing of monoclonal antibodies from mammalian cells
publisher University College London (University of London)
publishDate 2014
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626660
work_keys_str_mv AT tarrantrdr hostcellproteincharacterisationduringthedownstreamprocessingofmonoclonalantibodiesfrommammaliancells
_version_ 1718369642203840512